Stock listing

BOATS:SRZN Surrozen, Inc. Stock

US listing (BOATS) of Surrozen, Inc. · home listing NASDAQ:SRZN

Follow Surrozen, Inc. into a list and get an email when it puts out news.

Home listing price · NASDAQ:SRZN

$28.46 USD -3.28 (-10.3%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:SRZN

Past year +107.1% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$28.25 – $30.34 USDNov 20, 2026
Volume
148,849 sharesNov 20, 2026
Market cap
$542.5M USDAt the close on Nov 20, 2026 · price × 19.06M shares outstanding
52-week range
$12.79 – $37.83 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$15.45M USDMedian day 219,973 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Surrozen, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:SRZN · Home$28.46 USD-3.28 (-10.3%)148,849$29.92$30.34$28.25$31.74Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:SRZN · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$28.46-3.28-10.3%$29.92$30.34$28.25148,849
$31.74+1.76+5.9%$29.75$32.73$29.75312,926
$29.98-2.34-7.2%$31.86$31.88$29.30218,218
$32.32+0.71+2.2%$31.34$33.09$30.78274,400
$31.61-0.06-0.2%$32.34$32.87$30.40106,708
$31.67-0.21-0.7%$32.31$32.45$30.53134,041
$31.88-0.76-2.3%$33.43$33.74$31.69157,137
$32.64+0.64+2.0%$32.63$33.62$31.23197,895
$32.00+1.00+3.2%$31.32$33.50$31.09120,849
$31.00+2.00+6.9%$29.02$31.23$29.00140,726
$29.00-2.65-8.4%$31.36$31.36$28.68219,973
$31.65+1.53+5.1%$30.78$32.80$30.39231,054
$30.12+1.10+3.8%$29.52$30.24$28.53117,728
$29.02-0.02-0.1%$29.16$30.30$27.96159,249
$29.04-0.42-1.4%$29.32$29.51$27.72231,860
$29.46-0.89-2.9%$30.41$31.61$29.10254,712
$30.35+0.82+2.8%$29.45$30.53$29.45142,656
$29.53+2.25+8.2%$27.38$30.34$27.28431,554
$27.28+1.80+7.1%$25.23$27.75$24.97511,122
$25.48-0.27-1.0%$25.11$26.79$24.561,554,600
$25.75+0.43+1.7%$25.32$27.68$24.85137,000
$25.32+0.18+0.7%$25.78$26.09$24.98118,800
$25.14+1.30+5.5%$23.74$25.45$23.38323,900
$23.84+0.40+1.7%$23.51$24.48$23.25295,900
$23.44-1.63-6.5%$25.09$25.09$23.25269,000
$25.07+1.32+5.6%$23.73$25.32$23.31363,800
$23.75+0.24+1.0%$23.40$24.54$22.67631,500
$23.51-1.25-5.0%$24.04$24.37$21.85868,700
$24.76-4.93-16.6%$28.70$30.08$22.821,528,600
$29.69+1.72+6.1%$27.86$30.97$27.53781,300
$27.97+2.825+11.2%$25.00$28.85$23.54682,200
$25.15-1.225-4.6%$25.81$26.21$25.08374,200
$26.37-2.76-9.5%$29.26$29.26$26.18603,800
$29.13-0.19-0.6%$29.32$29.70$26.97439,200
$29.32-0.68-2.3%$30.57$30.68$28.93646,000
$30.00-2.18-6.8%$31.60$32.00$29.72438,400
$32.18+0.20+0.6%$32.16$33.38$30.981,656,600
$31.98+2.34+7.9%$29.83$32.55$29.50558,000
$29.64+0.10+0.3%$29.71$30.39$29.01409,700
$29.54-4.14-12.3%$34.72$37.83$28.551,928,700
$33.68+17.52+108.4%$30.56$35.86$29.1011,527,000
$16.16-1.44-8.2%$17.54$17.54$16.14115,500
$17.60+1.07+6.5%$16.78$17.60$16.5689,800
$16.53-0.02-0.1%$16.74$17.45$16.44129,000
$16.55-0.39-2.3%$16.97$17.68$16.43190,200
$16.94+0.01+0.1%$17.27$17.48$16.44268,500
$16.93-0.84-4.7%$17.84$17.86$16.78116,700
$17.77-0.07-0.4%$17.81$18.34$17.15151,900
$17.84-1.16-6.1%$19.03$19.29$17.61198,200
$19.00-0.45-2.3%$19.68$19.72$18.71145,300
$19.45-0.58-2.9%$19.95$20.15$19.00277,800
$20.03-0.65-3.1%$20.52$20.52$18.40201,900
$20.68-2.08-9.1%$22.57$23.18$20.63202,300
$22.76+0.22+1.0%$22.34$22.90$21.54150,200
$22.54-0.06-0.3%$22.92$22.99$22.24200,900
$22.60+0.40+1.8%$22.32$23.01$21.90116,900
$22.20+0.18+0.8%$21.72$22.48$21.65124,600
$22.02-0.40-1.8%$22.28$22.62$21.45266,700
$22.42-1.59-6.6%$23.75$23.75$22.08239,400
$24.01+0.30+1.3%$23.69$24.87$23.03340,700
$23.71+0.35+1.5%$23.52$24.16$23.19128,800
$23.36-0.61-2.5%$23.97$25.01$23.29218,967
$23.97-0.02-0.1%$23.81$24.33$22.80163,644
$23.99+0.49+2.1%$23.73$25.01$23.49149,700
$23.50-0.51-2.1%$24.46$24.46$23.09135,300

Splits

1 split · NASDAQ:SRZN · every price before a split is adjusted for it

DayRatioWhat
1-for-15Consolidation
Ticker
BOATS:SRZN
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
BOATS
Currency
USD

What changed lately

Latest news

All Surrozen, Inc. news

Surrozen, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
13 in the last 12 months · 50 in all · newest Nov 13, 2026 · oldest 2021
Calls
1 call with a replay · 1 with a transcript · latest Mar 23, 2023
Decks
7 decks · latest November 2026

Where Surrozen, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:SRZN · Home listingNASDAQUnited StatesUSD
BOATS:SRZN · This pageBOATSUnited StatesUSD

Valuation

EV/sales 42.5× against a median of 30.2×: 5th lowest of 8 Biotechnology companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$448.0M USD
P/E
Loss
EV/sales
42.5×
EV/EBITDA
Negative EBITDA
Price/book
Negative equity
Gross margin
5.0%
Operating margin
−485.4%
Net margin
Revenue too small
Debt to equity
Negative equity
Beta vs S&P 500
1.64

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Surrozen, Inc. · NASDAQ:SRZNUS$542.5MUS$448.0Mn/a42.5×n/an/an/an/a1.64
DBV Technologies SA · EURONEXT:DBVUS$571.8MUS$430.7Mn/a47.1×n/a3.9×n/a0.1×n/a
Ascletis Pharma, Inc. · HKEX:1672US$571.3MUS$232.4Mn/a765×n/a1.7×n/a0.0×n/a
4D Molecular Therapeutics, Inc. · NASDAQ:FDMTUS$565.1MUS$277.8Mn/a2.9×n/a1.7×−208.6%0.1×1.75
Bicara Therapeutics Inc. · NASDAQ:BCAXUS$560.3MUS$118.8Mn/an/an/a1.4×n/a0.0×1.37
Lepu Biopharma Co. Ltd. Class H · HKEX:2157US$554.8MUS$613.4M14.6×4.5×22.9×2.6×28.0%0.8×n/a
Aclaris Therapeutics, Inc. · NASDAQ:ACRSUS$545.6MUS$431.3Mn/a67.4×n/a3.3×n/a0.0×1.42
ArriVent BioPharma, Inc. · NASDAQ:AVBPUS$544.1MUS$151.2Mn/a30.2×n/a1.4×n/a0.0×1.18
Climb Bio, Inc. · NASDAQ:CLYMUS$539.8MUS$335.4Mn/an/an/a2.4×n/a0.0×1.44
Abbisko Cayman Limited · HKEX:2256US$518.9MUS$228.7Mn/an/an/a1.6×n/a0.2×n/a
Alumis Inc. · NASDAQ:ALMSUS$512.6MUS$116.5Mn/a16.1×n/a1.4×n/a0.1×1.58
Median of the othersUS$550.2MUS$255.1M14.6×30.2×22.9×1.7×−90.3%0.0×1.43

Forecasts

6 strong buy · Analysts' consensus from EODHD, read Nov 12, 2026. Not 6ix's view and not investment advice.

Price target
53.00 USD · Analysts' mean
EPS, year to Dec 2026
-18.78 · 1 analyst
Revenue, year to Dec 2026
10M · 4 analysts

Team and board

Officers

OfficerRole
Craig ParkerChief Executive Officer

Board

DirectorRole
Chris ChaiChair
David J. WoodhouseChairman of the Board
Tim KutzkeyChair
Craig ParkerChief Executive Officer
Mace RothenbergIndependent Board Member
Mary Haak-FrendschoIndependent Board Member

Events

Calls

CallWhenStatus
Surrozen (NASDAQ:SRZN) Q4 2022 Earnings CallThu, Mar 23, 2023 · 4:30 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 9, 2026 · After close+2.0%
Q2 2026Aug 14, 2026+0.2%
Q1 2026May 6, 2026 · After close−9.9%
Q4 2025Mar 24, 2026+3.6%
Q3 2025Nov 7, 2025 · After close−3.3%
Q2 2025Aug 8, 2025 · After close+4.5%
Q1 2025May 9, 2025 · After close−4.2%
Q4 2024Mar 31, 2025+1.0%
Q3 2024Nov 6, 2024 · Before open−5.1%
Q2 2024Aug 12, 2024 · After close−10.1%
All 20 quarters
QuarterResultsShare move
Q1 2024May 8, 2024 · After close+0.3%
Q4 2023Mar 19, 2024 · After close+8.0%
Q3 2023Nov 8, 2023 · After close−21.2%
Q2 2023Aug 9, 2023 · After close−32.2%
Q1 2023May 10, 2023 · After close−9.5%
Q4 2022Mar 22, 2023 · After close−22.6%
Q3 2022Nov 14, 2022 · After close−30.2%
Q2 2022Aug 11, 2022 · After close−3.3%
Q1 2022May 11, 2022 · After close+1.6%
Q4 2021Mar 24, 2022 · Before open−6.0%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (November 2026)Investor deck21 slidesNovember 2026
Investor Presentation (October 2026)Investor deck21 slidesOctober 2026
Investor Presentation (March 2026)Investor deck21 slidesMarch 2026
Investor Presentation (January 2026)Investor deck21 slidesJanuary 2026
Investor Presentation (April 2024)Investor deck24 slidesApr 1, 2024
Investor Presentation (August 2021)Investor deck36 slidesAug 12, 2021
SPAC Merger (April 2021)SPAC merger31 slidesApr 15, 2021

Open Decks

Financings

RaiseDate
Public offering of common stock
Announced: US$60M · US$31.67 a share · Morgan Stanley +2
Dealers: Morgan Stanley (co-lead), Guggenheim Securities (co-lead), Cantor (co-lead)
Buyers: Access Biotechnology; Boxer Capital Management; Perceptive Advisors; RTW Investments; Venrock Healthcare Capital Partners
Nov 13, 2026
At-the-market programme of common stock
Closed: US$29.8M raised
Use of proceeds: Strengthening the balance sheet and supporting the expansion of the DUET Phase 2a study
Nov 9, 2026
Warrant exercise of common stock warrants
Closed: US$1.1M raised
Nov 9, 2026
Private placement of common stock, pre-funded warrants and Series E common stock warrants
Closed: US$95.1M raised · Warrants at US$11.54
Use of proceeds: Strengthen balance sheet and fund cash runway into 2029, including the DUET Phase 1b/2a study of SZN-8141 and initial Phase 1b development of SZN-8143
Oct 20, 2026
Private placement of units of common stock (or pre-funded warrants) and accompanying common stock warrants
Tranche closed: US$76.4M raised · US$11.6 a unit · one half of a common stock warrant per unit · Guggenheim Securities, LLC
Dealers: Guggenheim Securities, LLC (lead)
Buyers: Venrock Healthcare Capital Partners (led the financing); The Column Group; Access Biotechnology; RA Capital Management; Vivo Capital; Spruce Street Capital; 5AM Ventures; Kalehua Capital; Samsara BioCapital; Acuta Capital Partners; StemPoint Capital; Braidwell LP
Use of proceeds: Funds multiple ophthalmology programs through Phase 1 safety, tolerability and efficacy studies
Mar 31, 2025

Open Financings · Read by 6ix AI from the company's releases

IPO

Went public as Consonance-HFW Acquisition Corp., a blank check company (SPAC). Priced at US$10.00 a unit on Nov 18, 2020.

Price
US$10.00 a unit
Units offered
8,000,000 units
Offering size
US$80 million
Underwriters' option
Up to 1,200,000 more units
Listing
CHFW.U on NYSE American
Underwriter
J.P. Morgan
Units delivered
On or about Nov 23, 2020

Steps

StepWhen
Draft sent to the SEC in confidenceSep 18, 2020
Filed publiclyOct 9, 2020
Amended 5 timesNewest Nov 12, 2020
Shares registered with an exchangeOct 19, 2020
Declared effective by the SECNov 18, 2020
Final prospectus, with the priceNov 19, 2020

Open IPO · From the cover of the final prospectus (424B4) filed Nov 19, 2020

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue3.48M10.7M012.5M00
Cost of revenue537.0K1.44M27.2M3.27M3.30M2.93M
Gross profit2.94M10.7M-27.2M12.5M-3.30M-2.93M
Research and development29.4M21.1M27.2M37.0M40.2M25.7M19.6M
Selling, general and administrative16.2M15.1M15.8M19.8M14.2M7.12M5.50M
Operating income-42.1M-25.5M-45.8M-44.3M-54.4M-32.8M-25.1M
Depreciation and amortization537.0K1.44M1.91M1.96M2.07M1.94M2.28M
EBITDA-41.6M-24.1M-43.9M-42.4M-52.3M-30.9M-22.8M
Interest expense1.96M2.07M91.0K0
Income before tax-242.0M-63.6M-43.0M-36.0M-54.6M-32.7M-24.4M
Income tax000000
Net income-242.0M-63.6M-43.0M-36.0M-54.6M-32.7M-24.4M
Earnings per share, basic-32.37-21.67-21.33-15.56-2.21-1.79-61.94
Earnings per share, diluted-32.37-21.67-21.33-15.56-2.21

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash and equivalents89.2M34.6M36.0M24.7M33.1M35.0M29.1M
Short-term investments051.1M68.8M14.2M
Receivables02.04M2.15M1.98M0
Inventory1
Current assets91.6M38.9M41.1M81.3M105.2M50.2M29.4M
Property, plant and equipment433.0K562.0K1.97M3.63M4.79M5.84M12.6M
Total assets98.7M48.5M46.1M89.4M137.2M62.1M42.5M
Accounts payable728.0K306.0K525.0K658.0K2.72M1.78M972.0K
Current liabilities9.93M7.32M7.15M9.73M13.6M7.28M3.90M
Total debt6.64M8.47M3.38M5.60M7.79M9.60M10.7M
Total liabilities286.5M69.8M8.14M13.4M27.5M14.8M13.1M
Shareholders' equity-187.8M-21.4M37.9M76.0M109.7M47.3M29.4M
Shares outstanding9.78M3.26M2.06M2.01M35.0M18.3M393.3K

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operations-30.2M-17.6M-40.4M-44.1M-48.8M-29.1M-21.1M
Capital spending-128.0K-26.0K-398.0K-728.0K-1.27M-874.0K-1.56M
Free cash flow-30.4M-17.7M-40.8M-44.9M-50.1M-30.0M-22.6M
Cash from investing-128.0K-26.0K51.7M38.3M-77.7M-15.1M-1.56M
Cash from financing85.1M16.2M276.0K-2.56M124.6M50.1M28.9M
Dividends paid-48.4M
Share buybacks198.0K94.0K0-2.61M0-1.00K-13.0K
Change in cash54.7M-1.48M11.6M-8.40M-1.89M5.88M29.5M

Open Financials

Filings

FilingDateTypeFiled with
SCHEDULE 13G/A · Big-stake notice, amendedNov 20, 2026Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedNov 18, 2026Big-stake noticeSEC
S-3 · Registration statementNov 18, 2026Offer documentSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 16, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 16, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 16, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 16, 2026Big-stake noticeSEC
424B5 · ProspectusNov 16, 2026Offer documentSEC
8-K · Current reportNov 16, 2026Material contractSEC
SCHEDULE 13G · Big-stake noticeNov 16, 2026Big-stake noticeSEC
Show 200 filings
FilingDateTypeFiled with
SCHEDULE 13G/A · Big-stake notice, amendedNov 13, 2026Big-stake noticeSEC
FWP · Free writing prospectusNov 13, 2026Offer documentSEC
10-Q · Quarterly reportNov 9, 2026Quarterly reportSEC
8-K · Current reportNov 9, 2026ResultsSEC
SCHEDULE 13D/A · Big-stake notice, amendedNov 6, 2026Big-stake noticeSEC
4 · Change in ownershipOct 22, 2026Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedOct 22, 2026Big-stake noticeSEC
4 · Change in ownershipOct 22, 2026Insider tradeSEC
8-K · Current reportOct 20, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedOct 7, 2026Big-stake noticeSEC
8-K · Current reportOct 2, 2026Current reportSEC
SCHEDULE 13G · Big-stake noticeOct 1, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeAug 14, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 11, 2026Big-stake noticeSEC
25-NSEAug 7, 2026Other filingsSEC
10-Q · Quarterly reportAug 6, 2026Quarterly reportSEC
8-K · Current reportAug 6, 2026ResultsSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 24, 2026Big-stake noticeSEC
4 · Change in ownershipJul 24, 2026Insider tradeSEC
4 · Change in ownershipJun 16, 2026Insider tradeSEC
4 · Change in ownershipJun 16, 2026Insider tradeSEC
4 · Change in ownershipJun 16, 2026Insider tradeSEC
4 · Change in ownershipJun 16, 2026Insider tradeSEC
4 · Change in ownershipMay 19, 2026Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedMay 18, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeMay 15, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2026Big-stake noticeSEC
4 · Change in ownershipMay 14, 2026Insider tradeSEC
4 · Change in ownershipMay 14, 2026Insider tradeSEC
4 · Change in ownershipMay 14, 2026Insider tradeSEC
4 · Change in ownershipMay 14, 2026Insider tradeSEC
4 · Change in ownershipMay 14, 2026Insider tradeSEC
4 · Change in ownershipMay 14, 2026Insider tradeSEC
8-K · Current reportMay 14, 2026Meeting outcomeSEC
10-Q · Quarterly reportMay 6, 2026Quarterly reportSEC
8-K · Current reportMay 6, 2026ResultsSEC
4 · Change in ownershipMay 5, 2026Insider tradeSEC
4 · Change in ownershipMay 5, 2026Insider tradeSEC
4 · Change in ownershipMay 5, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeApr 23, 2026Big-stake noticeSEC
4 · Change in ownershipApr 1, 2026Insider tradeSEC
ARS · Annual report to shareholdersApr 1, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 1, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 1, 2026Meeting noticeSEC
EFFECT · Notice that a registration is effectiveMar 31, 2026Other filingsSEC
424B5 · ProspectusMar 30, 2026Offer documentSEC
CORRESP · Letter to the SECMar 27, 2026Other filingsSEC
UPLOAD · Letter from the SECMar 27, 2026Other filingsSEC
4 · Change in ownershipMar 25, 2026Insider tradeSEC
S-8 · Registration statement for employee plansMar 23, 2026Offer documentSEC
S-3 · Registration statementMar 23, 2026Offer documentSEC
10-K · Annual reportMar 23, 2026Annual reportSEC
8-K · Current reportMar 23, 2026ResultsSEC
4 · Change in ownershipMar 16, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
4 · Change in ownershipFeb 18, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeFeb 17, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 17, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 17, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 13, 2026Big-stake noticeSEC
4 · Change in ownershipFeb 13, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 5, 2026Big-stake noticeSEC
4 · Change in ownershipFeb 3, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeFeb 2, 2026Big-stake noticeSEC
8-K · Current reportJan 30, 2026Management or board changeSEC
3 · Initial statement of ownershipJan 28, 2026Insider tradeSEC
4 · Change in ownershipJan 26, 2026Insider tradeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJan 22, 2026Big-stake noticeSEC
4 · Change in ownershipJan 20, 2026Insider tradeSEC
4 · Change in ownershipJan 20, 2026Insider tradeSEC
4 · Change in ownershipJan 15, 2026Insider tradeSEC
4 · Change in ownershipJan 15, 2026Insider tradeSEC
4 · Change in ownershipJan 8, 2026Insider tradeSEC
4 · Change in ownershipJan 8, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipJan 6, 2026Insider tradeSEC
4 · Change in ownershipDec 16, 2025Insider tradeSEC
4 · Change in ownershipDec 16, 2025Insider tradeSEC
4 · Change in ownershipDec 16, 2025Insider tradeSEC
4 · Change in ownershipDec 8, 2025Insider tradeSEC
4 · Change in ownershipDec 8, 2025Insider tradeSEC
4 · Change in ownershipDec 2, 2025Insider tradeSEC
SCHEDULE 13G · Big-stake noticeNov 20, 2025Big-stake noticeSEC
4 · Change in ownershipNov 17, 2025Insider tradeSEC
4 · Change in ownershipNov 13, 2025Insider tradeSEC
3 · Initial statement of ownershipNov 13, 2025Insider tradeSEC
10-Q · Quarterly reportNov 7, 2025Quarterly reportSEC
8-K · Current reportNov 7, 2025ResultsSEC
8-K · Current reportOct 17, 2025Current reportSEC
8-K · Current reportAug 29, 2025Material contractSEC
424B5 · ProspectusAug 29, 2025Offer documentSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedAug 13, 2025Big-stake noticeSEC
S-8 · Registration statement for employee plansAug 8, 2025Offer documentSEC
10-Q · Quarterly reportAug 8, 2025Quarterly reportSEC
8-K · Current reportAug 8, 2025ResultsSEC
4 · Change in ownershipJun 16, 2025Insider tradeSEC
4 · Change in ownershipJun 16, 2025Insider tradeSEC
4 · Change in ownershipJun 16, 2025Insider tradeSEC
EFFECT · Notice that a registration is effectiveMay 27, 2025Other filingsSEC
CORRESP · Letter to the SECMay 21, 2025Other filingsSEC
UPLOAD · Letter from the SECMay 21, 2025Other filingsSEC
S-3 · Registration statementMay 20, 2025Offer documentSEC
4 · Change in ownershipMay 15, 2025Insider tradeSEC
4 · Change in ownershipMay 15, 2025Insider tradeSEC
4 · Change in ownershipMay 15, 2025Insider tradeSEC
4 · Change in ownershipMay 15, 2025Insider tradeSEC
4 · Change in ownershipMay 15, 2025Insider tradeSEC
4 · Change in ownershipMay 15, 2025Insider tradeSEC
4 · Change in ownershipMay 15, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
8-K · Current reportMay 15, 2025Meeting outcomeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeMay 15, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 14, 2025Big-stake noticeSEC
10-Q · Quarterly reportMay 9, 2025Quarterly reportSEC
8-K · Current reportMay 9, 2025ResultsSEC
4 · Change in ownershipMay 5, 2025Insider tradeSEC
4 · Change in ownershipMay 5, 2025Insider tradeSEC
4 · Change in ownershipMay 5, 2025Insider tradeSEC
EFFECT · Notice that a registration is effectiveMay 2, 2025Other filingsSEC
424B5 · ProspectusMay 1, 2025Offer documentSEC
CORRESP · Letter to the SECApr 29, 2025Other filingsSEC
UPLOAD · Letter from the SECApr 29, 2025Other filingsSEC
424B5 · ProspectusApr 24, 2025Offer documentSEC
S-3 · Registration statementApr 23, 2025Offer documentSEC
DApr 8, 2025Other filingsSEC
SCHEDULE 13G · Big-stake noticeApr 2, 2025Big-stake noticeSEC
ARS · Annual report to shareholdersApr 2, 2025Annual reportSEC
SCHEDULE 13G · Big-stake noticeApr 2, 2025Big-stake noticeSEC
DEFA14A · Additional proxy materialApr 2, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 2, 2025Meeting noticeSEC
S-8 · Registration statement for employee plansMar 31, 2025Offer documentSEC
10-K · Annual reportMar 31, 2025Annual reportSEC
8-K · Current reportMar 31, 2025ResultsSEC
SCHEDULE 13G · Big-stake noticeMar 31, 2025Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedMar 28, 2025Big-stake noticeSEC
4 · Change in ownershipMar 28, 2025Insider tradeSEC
3 · Initial statement of ownershipMar 28, 2025Insider tradeSEC
4 · Change in ownershipMar 28, 2025Insider tradeSEC
8-K · Current reportMar 28, 2025Material contractSEC
4 · Change in ownershipMar 25, 2025Insider tradeSEC
4 · Change in ownershipMar 25, 2025Insider tradeSEC
8-K · Current reportMar 24, 2025Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeFeb 14, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
4 · Change in ownershipJan 22, 2025Insider tradeSEC
4 · Change in ownershipJan 22, 2025Insider tradeSEC
4 · Change in ownershipJan 22, 2025Insider tradeSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC
SCHEDULE 13G · Big-stake noticeNov 14, 2024Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeNov 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 13, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedNov 8, 2024Big-stake noticeSEC
10-Q · Quarterly reportNov 6, 2024Quarterly reportSEC
8-K · Current reportNov 6, 2024ResultsSEC
SC 13G · Big-stake noticeNov 1, 2024Big-stake noticeSEC
8-K · Current reportOct 2, 2024Material contractSEC
10-Q · Quarterly reportAug 12, 2024Quarterly reportSEC
8-K · Current reportAug 12, 2024ResultsSEC
8-K · Current reportJul 1, 2024Management or board changeSEC
4 · Change in ownershipJun 18, 2024Insider tradeSEC
4 · Change in ownershipJun 18, 2024Insider tradeSEC
4 · Change in ownershipJun 18, 2024Insider tradeSEC
8-K · Current reportJun 7, 2024Meeting outcomeSEC
4 · Change in ownershipJun 6, 2024Insider tradeSEC
4 · Change in ownershipJun 6, 2024Insider tradeSEC
4 · Change in ownershipJun 6, 2024Insider tradeSEC
4 · Change in ownershipJun 6, 2024Insider tradeSEC
4 · Change in ownershipJun 6, 2024Insider tradeSEC
4 · Change in ownershipJun 6, 2024Insider tradeSEC
4 · Change in ownershipJun 6, 2024Insider tradeSEC
4 · Change in ownershipJun 6, 2024Insider tradeSEC
10-Q · Quarterly reportMay 8, 2024Quarterly reportSEC
8-K · Current reportMay 8, 2024ResultsSEC

This page holds 200 of 513 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Surrozen, Inc.’s releases · as of Nov 13, 2026

Common shares
19,061,662
Fully diluted
22,078,909

Fully diluted

LineSharesAs of
Common shares19,061,662Nov 5, 2026
Warrants3,017,247Mar 26, 2025

Warrants and options

Lot
Warrants · US$11.54 · expiry not stated
Warrants · expiry not stated

Share count over time

CountShares
Nov 5, 202619,061,662

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Column Group LLC2.95M15.5%US$76.6MSep 30, 2026
Boxer Capital Management, LLC1.36M7.1%US$43.8MSep 30, 2026
Commodore Capital LP885K4.6%US$28.5MSep 30, 2026
Point72 Asset Management, L.P.806K4.2%US$26MSep 30, 2026
Venrock Adviser, LLC633K3.3%US$20.4MSep 30, 2026
Balyasny Asset Management L.P.626K3.3%US$20.2MSep 30, 2026
Millennium596K3.1%US$19.2MSep 30, 2026
Samlyn Capital, LLC504K2.6%US$16.2MSep 30, 2026
BlackRock499K2.6%US$16.1MSep 30, 2026
Kynam Capital Management, LP486K2.6%US$15.6MSep 30, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Vanguard481K2.5%US$15.5MSep 30, 2026
Perceptive Advisors LLC440K2.3%US$14.1MSep 30, 2026
Spruce Street Capital LP432K2.3%US$13.9MSep 30, 2026
Stempoint Capital LP419K2.2%US$11.1MSep 30, 2026
Rtw Investments, LP394K2.1%US$12.7MSep 30, 2026
Adage Capital Partners Gp, L.L.C.389K2.0%US$12.5MSep 30, 2026
Braidwell LP335K1.8%US$10.8MSep 30, 2026
Two Sigma326K1.7%US$10.5MSep 30, 2026
Integral Health Asset Management, LLC325K1.7%US$10.5MSep 30, 2026
Kalehua Capital Management LLC286K1.5%US$9.21MSep 30, 2026
Vivo Capital, LLC260K1.4%US$8.37MSep 30, 2026
UBS257K1.3%US$8.27MSep 30, 2026
Geode Capital195K1.0%US$6.27MSep 30, 2026
Fred Alger Management, LLC177K0.93%US$5.69MSep 30, 2026
Janus Henderson167K0.88%US$5.38MSep 30, 2026
Acuta Capital Partners, LLC153K0.80%US$4.91MSep 30, 2026
State Street136K0.72%US$4.39MSep 30, 2026
Regents Of The University Of California133K0.70%US$4.29MSep 30, 2026
Goldman Sachs113K0.59%US$3.63MSep 30, 2026
Euclidean Capital LLC87,6960.46%US$2.82MSep 30, 2026
Northern Trust63,4140.33%US$2.04MSep 30, 2026
Renaissance Technologies63,1360.33%US$2.03MSep 30, 2026
Jump Financial, LLC61,0840.32%US$1.97MSep 30, 2026
ArrowMark Colorado Holdings LLC55,1230.29%US$1.77MSep 30, 2026
AQR Capital Management LLC52,6700.28%US$1.69MSep 30, 2026
Stonepine Capital Management, LLC44,1000.23%US$1.42MSep 30, 2026
BNP Paribas40,8520.21%US$1.31MSep 30, 2026
Trexquant Investment LP39,3450.21%US$1.27MSep 30, 2026
Citadel35,5710.19%US$1.14MSep 30, 2026
Man Group plc35,5150.19%US$1.14MSep 30, 2026
Longaeva Partners L.P.32,9410.17%US$1.06MSep 30, 2026
T. Rowe Price27,7410.15%US$893KSep 30, 2026
Jane Street25,3320.13%US$815KSep 30, 2026
Squarepoint Ops LLC22,2620.12%US$716KSep 30, 2026
Informed Momentum Co LLC21,1390.11%US$680KSep 30, 2026
Lynx1 Capital Management LP20,0000.10%US$644KSep 30, 2026
Sphera Funds Management LTD.18,8210.10%US$606KSep 30, 2026
Schwab18,0220.09%US$580KSep 30, 2026
BNY17,1190.09%US$551KSep 30, 2026
Algert Global LLC16,4300.09%US$529KSep 30, 2026

This page holds 50 of 87 holders. Open Shareholders

Funds

HolderSharesOf the companyValueAs of
Vanguard Total Stock Market Index Fund282K1.5%US$7.33MJun 30, 2026
iShares Russell 2000 ETF161K0.85%US$4.19MJun 30, 2026
Vanguard Extended Market Index Fund103K0.54%US$2.67MJun 30, 2026
Fidelity Small Cap Index Fund80,2680.42%US$1.78MJul 31, 2026
iShares Russell 2000 Growth ETF62,4260.33%US$1.62MJun 30, 2026
Fidelity Extended Market Index Fund26,5130.14%US$695KMay 31, 2026
iShares Micro-Cap ETF23,6610.12%US$614KJun 30, 2026
Schwab Small-Cap Index Fund18,0220.09%US$400KJul 31, 2026
Master Small Cap Index Series12,4110.07%US$322KJun 30, 2026
Fidelity Total Market Index Fund11,8360.06%US$310KMay 31, 2026
Show 50 holders
HolderSharesOf the companyValueAs of
Nuveen Small Cap Blend Index Fund9,7800.05%US$217KJul 31, 2026
Fidelity Series Total Market Index Fund8,5840.05%US$225KMay 31, 2026
EQ/2000 Managed Volatility Portfolio7,0840.04%US$184KJun 30, 2026
Fidelity Small Cap Growth Index Fund6,8690.04%US$178KJun 30, 2026
Fidelity Nasdaq Composite Index Fund6,1430.03%US$161KMay 31, 2026
LVIP State Street Small-Cap Index Fund5,5000.03%US$143KJun 30, 2026
Small Cap Index Fund3,7900.02%US$98,351Jun 30, 2026
Vanguard Institutional Total Stock Market Index Fund3,7510.02%US$97,338Jun 30, 2026
Global X Russell 2000 ETF3,5220.02%US$78,224Jul 31, 2026
State Street Small/Mid Cap Equity Index Portfolio3,5000.02%US$90,825Jun 30, 2026
Vanguard Balanced Index Fund3,4950.02%US$90,695Jun 30, 2026
ATM Small Cap Managed Volatility Portfolio2,7400.01%US$71,103Jun 30, 2026
MetLife Russell 2000 Index Portfolio2,6630.01%US$69,105Jun 30, 2026
Small-Cap Index Portfolio1,860<0.01%US$48,267Jun 30, 2026
Small Cap Index Trust1,669<0.01%US$43,311Jun 30, 2026
iShares Russell Small/Mid-Cap Index Fund1,611<0.01%US$35,780Jul 31, 2026
1290 VT Micro Cap Portfolio1,575<0.01%US$40,871Jun 30, 2026
NVIT Small Cap Index Fund1,474<0.01%US$38,250Jun 30, 2026
EQ/AB Small Cap Growth Portfolio1,270<0.01%US$32,957Jun 30, 2026
EQ/Small Company Index Portfolio1,270<0.01%US$32,957Jun 30, 2026
Tiff Multi-Asset Fund1,231<0.01%US$31,944Jun 30, 2026
DWS Small Cap Index VIP1,149<0.01%US$29,817Jun 30, 2026
T. Rowe Price Small-Cap Index Fund1,108<0.01%US$28,753Jun 30, 2026
EQ/Morgan Stanley Small Cap Growth Portfolio990<0.01%US$25,691Jun 30, 2026
Voya RussellTM Small Cap Index Portfolio947<0.01%US$24,575Jun 30, 2026
BlackRock Small Cap Index V.I. Fund881<0.01%US$22,862Jun 30, 2026
SA Small Cap Index Portfolio860<0.01%US$19,101Jul 31, 2026
CVT Russell 2000 Small Cap Index Portfolio666<0.01%US$17,283Jun 30, 2026
Victory Extended Market Index Fund644<0.01%US$14,303Jul 31, 2026
Nationwide Small Cap Index Fund638<0.01%US$14,170Jul 31, 2026
PD Small-Cap Growth Index Portfolio599<0.01%US$15,544Jun 30, 2026
Venerable Small Cap Index Fund587<0.01%US$15,233Jun 30, 2026
Voya VACS Index Series SC Portfolio584<0.01%US$15,155Jun 30, 2026
SmallCap Growth Fund I561<0.01%US$12,460Jul 31, 2026
Strategic Equity Allocation Trust364<0.01%US$9,446Jun 30, 2026
EQ/Franklin Small Cap Value Managed Volatility Portfolio225<0.01%US$5,839Jun 30, 2026
Penn Series Small Cap Index Fund200<0.01%US$5,190Jun 30, 2026
Total Stock Market Index Trust198<0.01%US$5,138Jun 30, 2026
State Street Total Return V.I.S. Fund185<0.01%US$4,801Jun 30, 2026
Ultra Small Cap Profund95<0.01%US$2,110Jul 31, 2026

This page holds 50 of 57 holders. Open Shareholders

Insider trades

TradeTradeSharesPriceValueDate
Yu Chen-Ming
10% owner
Sale162,500USD 21.25US$3.45MJul 22, 2026
Parker Craig C
Director, Officer: Chief Executive Officer
Sale4,524USD 33.33US$151KMay 4, 2026
Williams Charles O
Officer: Chief Operating Officer
Sale2,036USD 33.33US$67,860May 4, 2026
Li Yang
Officer: Exec. Vice President, Research
Sale1,584USD 33.33US$52,795May 4, 2026

Big stakes

StakeStakeSharesDateFiling
Tim Kutzkey18.20%3.81MNov 16, 2026Schedule 13D
Boxer Capital Management, LLC11.60%1.36MSep 30, 2026Schedule 13G
AI Biotechnology LLC9.90%2.21MNov 16, 2026Schedule 13G
Venrock Healthcare Capital Partners III, L.P.9.90%1.21MMar 31, 2026Schedule 13G
Ra Capital Management, L.P.9.20%872KDec 31, 2025Schedule 13G
Commodore Capital LP7.50%885KSep 24, 2026Schedule 13G
Point72 Asset Management, L.P.6.90%806KSep 30, 2026Schedule 13G
Balyasny Asset Management L.P.5.61%659KSep 30, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Eric H. Bjerkholt
Other companies: Mirum Pharmaceuticals, Inc. (CHIEF FINANCIAL OFFICER · Since at least Aug 11, 2025); Cerus Corporation (Director · Since at least Jun 3, 2025); Metagenomi Therapeutics, Inc. (Director · Since at least Jan 16, 2025)
Director · Since at least May 14, 2025
Christopher Haqq
Other companies: Elicio Therapeutics, Inc. (Executive Vice President, Head of Research and Development and Chief Medical Officer · Since at least Jun 1, 2023); Atara Biotherapeutics, Inc. (EVP, R&D & Chief Scientific Of · Oct 15, 2014 – Feb 15, 2019 · Past)
Director · Nov 18, 2020 – Nov 18, 2020 · Past
Anna Berkenblit
Other companies: ImmunoGen Inc (SVP & CHIEF MEDICAL OFFICER · May 20, 2022 – Jun 30, 2023 · Past)
Director · Since at least Jun 7, 2022
Christopher Y Chai
Other companies: Principia Biopharma Inc (Chief Financial Officer · Sep 13, 2018 – Sep 28, 2020 · Past)
Director · Since at least Aug 11, 2021
David J. Woodhouse
Other companies: NGM Biopharmaceuticals Inc (Chief Executive Officer, Director · Apr 3, 2019 – Apr 5, 2024 · Past)
Chairman of the Board · Since at least Aug 11, 2021
Geertrui Vanhove
Other companies: INSYS Therapeutics Inc (Director · Apr 2, 2018 – Apr 2, 2018 · Past)
Chief Medical Officer · Aug 11, 2021 – Dec 15, 2022 · Past
Mace Rothenberg
Other companies: Tango Therapeutics, Inc. (Director · Since at least Aug 10, 2021)
Director · Since at least Aug 11, 2021
Andrew Pedrum MalekiChief Financial Officer · Since at least Nov 12, 2025
Benny SofferDirector · Nov 18, 2020 – Dec 1, 2020 · Past
Charles O WilliamsChief Operating Officer · Since at least Aug 11, 2021
All 19 people
PersonSeat
Chris ChaiChair · Since at least Nov 4, 2026
Craig ParkerChief Executive Officer, Director · Since at least May 1, 2026
Kevin Harold LivingstonChief Financial Officer · Nov 18, 2020 – Dec 1, 2020 · Past
Life Sciences ConsonanceDirector · Nov 18, 2020 – Dec 1, 2020 · Past
Mary Haak-FrendschoIndependent Board Member · Since at least Nov 4, 2026
Tim KutzkeyDirector · Since at least Aug 11, 2021
Tim KutzkeyChair · Since at least Mar 24, 2025
Wen-Chen YehChief Scientific Officer · Aug 11, 2021 – Jun 15, 2023 · Past
Yang LiExec. Vice President, Research · Since at least Aug 17, 2023

Open People

Log in to ask 6ix AI your own questions about Surrozen, Inc.